Brief: Chemocentryx Inc Says ACR Convergence 2020 Will Feature Plenary Session Presentation On Advocate Phase III Trial Results Of Avacopan

Churchill Capital XI

06/11/2020 13:34

Nov 6 (Reuters) - ChemoCentryx Inc  CCXI.O :
    * CHEMOCENTRYX INC -  ACR CONVERGENCE 2020 WILL FEATURE A
PLENARY
SESSION PRESENTATION ON ADVOCATE PHASE III TRIAL RESULTS OF
AVACOPAN

Source text for Eikon:  ID:nGNX2H7XKt 
Further company coverage:  CCXI.O 

 ((Reuters.Briefs@thomsonreuters.com;))